European Biotech Acquisition Corp. Quarterly Liabilities, Current in USD from Q1 2021 to Q4 2022

Taxonomy & unit: us-gaap: USD
Description: Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Summary: European Biotech Acquisition Corp. quarterly Liabilities, Current history and growth rate from Q1 2021 to Q4 2022.
European Biotech Acquisition Corp. Liabilities, Current for the quarter ending December 31, 2022 was $796K, a 57.5% increase year-over-year.

Liabilities, Current, Quarterly (USD)

Liabilities, Current, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q4 2022	$796K	+$290K	+57.5%	Dec 31, 2022	10-K	2023-02-28
Q3 2022	$1.35M	+$1.12M	+476%	Sep 30, 2022	10-Q	2022-11-14
Q2 2022	$437K	+$211K	+93.6%	Jun 30, 2022	10-Q	2022-08-15
Q1 2022	$529K	-$291K	-35.5%	Mar 31, 2022	10-Q	2022-05-16
Q4 2021	$505K			Dec 31, 2021	10-K	2023-02-28
Q3 2021	$235K			Sep 30, 2021	10-Q	2021-11-23
Q2 2021	$225K			Jun 30, 2021	10-Q	2021-08-18
Q1 2021	$820K			Mar 31, 2021	10-Q	2021-06-22

* An asterisk sign (*) next to the value indicates that the value is likely invalid.